Insider Transactions in Q3 2021 at Imago Bio Sciences, Inc. (IMGO)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2021
|
Omega Fund Vi, L.P. |
BUY
Conversion of derivative security
|
Direct |
2,768,737
+30.72%
|
-
|
|
Jul 20
2021
|
Patrick J Heron Director |
BUY
Conversion of derivative security
|
Indirect |
2,783,774
+27.41%
|
-
|
|
Jul 20
2021
|
Patrick J Heron Director |
BUY
Open market or private purchase
|
Indirect |
187,500
+50.0%
|
$3,000,000
$16.0 P/Share
|
|
Jul 20
2021
|
Clarus Lifesciences Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
150,000
+4.26%
|
$2,400,000
$16.0 P/Share
|
|
Jul 20
2021
|
Clarus Lifesciences Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,225,037
+27.79%
|
-
|
|
Jul 15
2021
|
Robert Baltera Jr. Director |
BUY
Open market or private purchase
|
Indirect |
850
+50.0%
|
$13,600
$16.0 P/Share
|
|
Jul 15
2021
|
Omega Fund Vi, L.P. |
BUY
Open market or private purchase
|
Direct |
250,000
+50.0%
|
$4,000,000
$16.0 P/Share
|